Afacifenacin Fumarate
- Generic Name
- Afacifenacin Fumarate
SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)
- First Posted Date
- 2006-12-11
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 550
- Registration Number
- NCT00409539
- Locations
- 🇪🇪
Tartu University Clinic, Tartu, Estonia
🇵🇱Medical University of Selesia, Katowice, Poland
🇵🇱UI.G. Narutowicza 28, Lodz, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath